In the BioHarmony Drug Report Database

"Preview" Icon

Amlexanox

Amlexanox, Aphthasol (amlexanox) is a small molecule pharmaceutical. Amlexanox was first approved as Amlexanox on 1996-12-17. It is used to treat atopic dermatitis, rhinitis, and ulcer in the USA. It is known to target serine/threonine-protein kinase TBK1 and inhibitor of nuclear factor kappa-B kinase subunit epsilon.

 

Trade Name

 

Amlexanox, Aphthasol
 

Common Name

 

amlexanox
 

ChEMBL ID

 

CHEMBL1096
 

Indication

 

atopic dermatitis, rhinitis, ulcer
 

Drug Class

 

Antiallergic respiratory tract drugs (xanoxic acid derivatives)

Image (chem structure or protein)

Amlexanox structure rendering